EMEA-002950-PIP01-20

Key facts

Invented name
Lutathera
Active substance
lutetium (177Lu) oxodotreotide
Therapeutic area
Oncology
Decision number
P/0503/2021
PIP number
EMEA-002950-PIP01-20
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of gastroenteropancreatic neuroendocrine tumours
Route(s) of administration
Intravenous use
Contact for public enquiries
Advanced Accelerator Applications

Email: infomed@adacap.com    
Tel. +33 (0)450993070

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

Related content

How useful was this page?

Add your rating